2007
DOI: 10.1080/10903120701537147
|View full text |Cite
|
Sign up to set email alerts
|

A Descriptive Analysis of Emergency Medical Service Systems Participating in the Resuscitation Outcomes Consortium (ROC) Network

Abstract: Similarities and differences among EMS systems participating in the ROC network were described. The framework used in this analysis may serve as a template for future EMS research.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
134
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 143 publications
(138 citation statements)
references
References 33 publications
4
134
0
Order By: Relevance
“…1). Approximately 23.7 million persons were served by the participating EMS agencies from the 11 ROC geographic areas (Table 2) 15 . Aeromedical calls were included if they occurred in the geographical area covered by a ROC land ambulance service.…”
Section: Settingmentioning
confidence: 99%
“…1). Approximately 23.7 million persons were served by the participating EMS agencies from the 11 ROC geographic areas (Table 2) 15 . Aeromedical calls were included if they occurred in the geographical area covered by a ROC land ambulance service.…”
Section: Settingmentioning
confidence: 99%
“…4,5 One way that community response to OHCA differs is in the number of emergency medical services (EMS) personnel dispatched to provide on-scene treatment. 6 This generally depends on EMS organizational structure. Accordingly, we sought to examine patterns of association between number of EMS personnel on-scene and survival to hospital discharge in adults with EMS-treated.…”
Section: Introductionmentioning
confidence: 99%
“…9 Paramedics from 55 emergency medical services (EMS) agencies enrolled patients with out-of-hospital cardiac arrest at 10 North American sites participating in the Resuscitation Outcomes Consortium (ROC). 10 The trial was conducted under exception from informed consent in emergency research in accordance with applicable regulatory requirements, oversight by the Food and Drug Administration and Health Canada, approval by institutional review boards in participating communities, and monitoring by an independent data and safety monitoring board appointed by the National Heart, Lung, and Blood Institute (NHLBI).…”
Section: Trial Conduct and Oversightmentioning
confidence: 99%
“…The initial dose of a trial drug, approximating current clinical practice, consisted of two syringes (one syringe if the estimated body weight was <100 lb [45.4 kg]) that were administered by rapid bolus. 10,15,16 If ventricular fibrillation or pulseless ventricular tachycardia persisted after the initial dose of the trial drug, standard resuscitation measures, and additional shocks, a supplemental dose (one syringe) of the same drug was administered. Thereafter, standard interventions for advanced life support ensued according to local practice, excluding open-label lidocaine or amiodarone before hospitalization.…”
Section: Treatment Protocolmentioning
confidence: 99%